MCh Pediatric Orthopedics: Admission, Medical School, Fees, Eligibility Criteria

Published Date: 06 Mar 2023

The Master Chirurgiae in Pediatric Orthopedics, also known as MCh Pediatric Orthopedics or MCh in Pediatric Orthopedics, is the highest degree...

Read Full News

Latest News

AbbVie's Blood Cancer Therapy Lowers Disease Progression, Death Risk in Trial

AbbVie said on Thursday its therapy for a type of blood cancer has improved patients' response rate ⁠to treatment and reduced the risk of disease progression or death,...

Less Frequent Monitoring May Be Safe in Patients on MTX

For patients on methotrexate, routine monitoring every 6 months vs 3 months is not linked to an increase in laboratory or blood count abnormalities.

Gout Tied to Elevated Fracture Risk; Drug Adherence Helps

A recent diagnosis of gout is associated with an increased risk for fractures, and high adherence to allopurinol may help mitigate this elevated risk.

BMI Affects Response to JAK Inhibitors in RA

A higher BMI is associated with a reduced response to JAK inhibitors in patients with rheumatoid arthritis.

Meet the Doctor for the New York Knicks

A Q&A with Daphne Scott

Aspirin Alone Gets the Job Done for Clot Prevention After Joint Surgery

Regimens may drop the direct anticoagulants for some patients, based on EPCAT III

Todays Updates

First-Line T-DXd Boosts PFS in HER2-Mutant NSCLC

DESTINY-Lung04 supports trastuzumab deruxtecan as a new frontline option for patients with advanced HER2-mutant disease, though it failed to improve overall survival.

Could Burnout Become the Employer’s Responsibility?

A European Parliament committee is backing employer risk assessments to tackle burnout. But should that mean new binding EU rules?

High CLL Remission Seen With First-Line Triplet Regimen

High 2-year survival rates are seen in treatment-naive patients with CLL receiving a noncovalent BTK inhibitor combined with venetoclax and obinutuzumab.

FET-PET Agent Approved for Glioma Imaging

Floretyrosine F18 is the first amino acid PET imaging agent approved for glioma in the United States.

Todays Updates

First-Line T-DXd Boosts PFS in HER2-Mutant NSCLC

DESTINY-Lung04 supports trastuzumab deruxtecan as a new frontline option for patients with advanced HER2-mutant disease, though it failed to improve overall survival.

Could Burnout Become the Employer’s Responsibility?

A European Parliament committee is backing employer risk assessments to tackle burnout. But should that mean new binding EU rules?

High CLL Remission Seen With First-Line Triplet Regimen

High 2-year survival rates are seen in treatment-naive patients with CLL receiving a noncovalent BTK inhibitor combined with venetoclax and obinutuzumab.

FET-PET Agent Approved for Glioma Imaging

Floretyrosine F18 is the first amino acid PET imaging agent approved for glioma in the United States.

Latest News

AbbVie said on Thursday its therapy for a type of blood cancer has improved patients' response rate ⁠to treatment and reduced the risk of disease progression or death,...

For patients on methotrexate, routine monitoring every 6 months vs 3 months is not linked to an increase in laboratory or blood count abnormalities.

A recent diagnosis of gout is associated with an increased risk for fractures, and high adherence to allopurinol may help mitigate this elevated risk.

A higher BMI is associated with a reduced response to JAK inhibitors in patients with rheumatoid arthritis.

A Q&A with Daphne Scott

Regimens may drop the direct anticoagulants for some patients, based on EPCAT III

News All Time

Synovitis Confirmed as Prognostic in Hand Osteoarthritis, Regardless of Subtype

— Doesn't matter whether it's in the first carpometacarpal or interphalangeal joints

Denosumab May Protect Joints in Adults With Osteoporosis

Starting denosumab is associated with a modestly lower risk of developing osteoarthritis than starting oral bisphosphonates among adults with osteoporosis.

Straight Talk on Scoliosis Screening in Primary Care

Pediatricians can and should screen for scoliosis, especially in teens who are still growing.

Real-World Strategies to Improve Multidisciplinary Care Coordination of TGCT

Real-World Strategies to Improve Multidisciplinary Care Coordination of TGCT

Real-World Strategies to Improve Multidisciplinary Care Coordination of TGCT

Real-World Strategies to Improve Multidisciplinary Care Coordination of TGCT

Did Your Patient’s Cane Kill Them?

Mobility assistance devices may be harmful if not prescribed properly

Trial Casts Doubt on Antibiotics for Refractory Low Back Pain

Now it's up to clinicians to sort out conflicting evidence

GLP-1 Drugs Tied to Lower Need for Knee Replacement

But what drives the apparent effect remains unknown. Is it the weight loss or other factors?

Top Pro Athletes Credit a Tiny New Scope for Their Faster Recoveries

There's little published research, but a small, flexible arthroscope is accumulating proponents

Cancer Diagnosis Delays During Screening Study; Benefits of Resistance Training

Also in TTHealthWatch: GLP-1 agonists and knee replacement

Woman's Ice-Skating Fall Produces Striking X-Ray, Rare Forearm Break

While Monteggia fracture is uncommon in adults, early intervention is crucial

The World Cup Is a Celebration of Sport. It's Also a Warning About Climate Change.

The tournament is a preview for how outdoor activities are being reshaped globally

Why Some 'Old' Soccer Players Like Messi, Ronaldo Can Still Kick It in the World Cup

Advancements in training and recovery means elite athletes are playing longer than ever before

FDA Declines to Approve Sobi's Gout Therapy on Concerns Over Manufacturing

The U.S. Food and Drug Administration declined to approve Swedish drugmaker Sobi's therapy to treat uncontrolled ⁠gout, a common form of inflammatory arthritis, the company...

Optimizing the Use of Disease-Modifying Therapies Across the Spinal Muscular Atrophy Care Continuum: An Expert TheraTalk

Optimizing the Use of Disease-Modifying Therapies Across the Spinal Muscular Atrophy Care Continuum: An Expert TheraTalk

Doctor Tripped Up by $64,000 Bill for Ankle Surgery and Hospital Stay

An insurance contract quirk leads to a claim denial

Recommended News For You

Studies show that treatment for non-Hodgkin's lymphoma is also focused on the lymphoma.

Alecensa (alectinib) Offers Hope for Certain Patients With ALK Positive NSCLC

What Dolph Lundgren's journey from terminal diagnosis to 'cancer free' can tell us about cancer care

Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patients

In breast-conserving surgery, is micro-CT a useful tool for determining tumor margins?

'Full House' Star's Cancer; Fluoride Fears Go Mainstream; Florida Doctor Arrested

The way that miR-377 inhibits cells that cause prostate cancer.

Recommended Articles For You

Unraveling the Mystery of Non-Caseating Granulomas: A Comprehensive Guide 

Revolutionizing Cancer Care: The Transformative Role of AI and Data Science in Oncology 

Next-Generation Bone Marrow Harvest Technologies 

Next-Gen Cancer Therapies: Radiopharmaceuticals, Immuno-Oncology, and Biologic Breakthroughs 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Inside the Major Findings From the NHS-Galleri Trial

2.

De-escalation Misses the Mark in Inflammatory Breast Cancer

3.

Major Shifts in Urothelial Cancer Care: Immunotherapy Redefines Standards

4.

Minimally invasive prostate cancer treatment shows success in first patient

5.

Why are so many young adults getting cancer?

1.

Lentigo Maligna Melanoma: Everything You Need To Know about This Skin Cancer

2.

The Bloodstream Compass: A Comparative Clinical Review of Liquid Biopsy and AI in Predictive Oncology

3.

Understanding Mean Corpuscular Volume: A Comprehensive Guide 

4.

Beyond the Biopsy: Decoding Tumor Biology Through the Lens of Radiogenomics

5.

The latest Hematocrit: An Overview of Red Blood Cell Health 

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Latest Advances in Hematology

2.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III

3.

Emerging Concepts in Hematology

4.

Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care

5.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot